Compile Data Set for Download or QSAR
Report error Found 549 Enz. Inhib. hit(s) with all data for entry = 10309
TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526672(US11186577, Cmpd. No. 1)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526673(US11186577, Cmpd. No. 2)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526674(US11186577, Cmpd. No. 3)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526675(US11186577, Cmpd. No. 4)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526677(US11186577, Cmpd. No. 6)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526679(US11186577, Cmpd. No. 8)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526687(US11186577, Cmpd. No. 16)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526692(US11186577, Cmpd. No. 28)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526700(US11186577, Cmpd. No. 36)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526701(US11186577, Cmpd. No. 37)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526702(US11186577, Cmpd. No. 38)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526703(US11186577, Cmpd. No. 39)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526704(US11186577, Cmpd. No. 40)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526705(US11186577, Cmpd. No. 41)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526705(US11186577, Cmpd. No. 41)
Affinity DataIC50: 100nMAssay Description:The purpose of the assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin receptor 2. The assay was performed in co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526706(US11186577, Cmpd. No. 42)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V2 receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526706(US11186577, Cmpd. No. 42)
Affinity DataIC50: 100nMAssay Description:The purpose of the assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin receptor 2. The assay was performed in co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526707(US11186577, Cmpd. No. 43)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526708(US11186577, Cmpd. No. 44)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526709(US11186577, Cmpd. No. 45)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526710(US11186577, Cmpd. No. 46)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526711(US11186577, Cmpd. No. 47)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526712(US11186577, Cmpd. No. 48)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526713(US11186577, Cmpd. No. 49)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526714(US11186577, Cmpd. No. 50)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526716(US11186577, Cmpd. No. 52)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526717(US11186577, Cmpd. No. 53)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526718(US11186577, Cmpd. No. 54)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526720(US11186577, Cmpd. No. 56)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526721(US11186577, Cmpd. No. 57)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526722(US11186577, Cmpd. No. 58)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526723(US11186577, Cmpd. No. 59)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526725(US11186577, Cmpd. No. 61)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526726(US11186577, Cmpd. No. 62)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526727(US11186577, Cmpd. No. 63)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526728(US11186577, Cmpd. No. 64)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526729(US11186577, Cmpd. No. 65)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526731(US11186577, Cmpd. No. 67)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526732(US11186577, Cmpd. No. 68)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526733(US11186577, Cmpd. No. 69)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526734(US11186577, Cmpd. No. 70)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526735(US11186577, Cmpd. No. 71)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526736(US11186577, Cmpd. No. 72)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526737(US11186577, Cmpd. No. 73)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526738(US11186577, Cmpd. No. 74)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526739(US11186577, Cmpd. No. 75)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526740(US11186577, Cmpd. No. 78)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526741(US11186577, Cmpd. No. 79)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526742(US11186577, Cmpd. No. 81)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

TargetVasopressin V1a receptor(Human)
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526743(US11186577, Cmpd. No. 82)
Affinity DataIC50: 100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/10/2022
Entry Details
Go to US Patent

Displayed 1 to 50 (of 549 total ) | Next | Last >>
Jump to: